Many drugs used for rheumatic disease cause neutropenia
Authors:
Abstract
We agree with Hay and colleagues that, although neutropenia worries clinicians, it is often an unimportant finding and rarely requires treatment.1 Drug induced neutropenia is common in patients with rheumatic disease. We recognise that this is an increasing problem in primary care. It rarely leads to an alteration in the patient’s management, although it causes concern to non-specialists. We would like …Keywords
This publication has 4 references indexed in Scilit:
- Neutropenia in primary careBMJ, 2014
- Management of immune cytopenias in patients with systemic lupus erythematosus — Old and newAutoimmunity Reviews, 2013
- Double‐blind randomized controlled clinical trial of the interleukin‐6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexateArthritis & Rheumatism, 2006
- Neutropenia in Patients Treated with RituximabNew England Journal of Medicine, 2003